Y-Intercept (HK)’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
Y-Intercept (HK)'s CRDF Position: Q2 2026 in Review
Y-Intercept (HK) opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 22,388 shares worth $29.1K. The stake represents ﹤0.01% of the portfolio and ranks #1638 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in CRDF as recently as Q1 2024.
Y-Intercept (HK) first reported a position in CRDF in Q1 2024 and has held it in 2 quarters since. The position peaked at $157K in Q1 2024. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Y-Intercept (HK) held 22,388 shares of Cardiff Oncology worth $29.1K as of Q2 2026.
- Cardiff Oncology was a new Y-Intercept (HK) position in Q2 2026.
- Cardiff Oncology made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1638 holding.
- Y-Intercept (HK) first reported a position in Cardiff Oncology in Q1 2024 and has held it in 2 quarters since.
- Y-Intercept (HK)'s Cardiff Oncology position peaked at $157K in Q1 2024.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.